Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
3.465
-0.045 (-1.28%)
Mar 31, 2025, 1:41 PM EDT - Market open
Third Harmonic Bio Market Cap
Third Harmonic Bio has a market cap or net worth of $156.29 million as of March 31, 2025. Its market cap has decreased by -59.83% in one year.
Market Cap
156.29M
Enterprise Value
-123.54M
1-Year Change
-59.83%
Ranking
Category
Stock Price
$3.47
Market Cap Chart
Since the IPO on September 15, 2022, Third Harmonic Bio's market cap has decreased from $657.80M to $156.29M, a decrease of -76.24%. That is a compound annual growth rate of -43.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 158.31M | -65.85% |
| Dec 31, 2024 | 463.65M | 4.71% |
| Dec 29, 2023 | 442.78M | 153.97% |
| Dec 30, 2022 | 174.34M | -73.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.47B |
| UnitedHealth Group | 479.26B |
| Johnson & Johnson | 400.85B |
| AbbVie | 370.23B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 229.14B |
| Merck & Co. | 225.10B |